Biogen teaming with Cigna, CVS Health to increase access to its Alzheimer’s drug

When the U.S. Food and Drug Administration approved aducanumab, an Alzheimer's medication from drugmaker Biogen, there was controversy as to whether the drug was actually effective. But that hasn't stopped Biogen from teaming up with major payers, including Cigna and CVS Health, to increase patient access to the drug.

Read the full post at News Feed
Vote This Post DownVote This Post Up (No Ratings Yet)
Explore the Archive